Federal Register / Vol. 74, No. 185 / Friday, September 25, 2009 / Notices 49021 

Drug Schedule 

3,4–Methylendioxy-Nethylamphetamine (7404).I 

3,4– 

Methylenedioxymethamphetamine (7405).

I 

4–Methoxyamphetamine (7411) ... I 

Alpha-methyltryptamine (7432) .... I 

Bufotenine (7433) ......................... I 

Diethyltryptamine (7434) .............. I 

Dimethyltryptamine (7435) ........... I 

Psilocybin (7437) .......................... I 

Psilocyn (7438) ............................. I 

5–Methoxy-N,Ndiisopropyltyptamine (7439).I 

N–Benzylpiperazine (7493) .......... I 

Acetyldihydrocodeine (9051) ........ I 

Benzylmorphine (9052) ................ I 

Codeine-N-oxide (9053) ............... I 

Dihydromorphine (9145) ............... I 

Heroin (9200) ............................... I 

Hydromorphinol (9301) ................. I 

Methyldihydromorphine (9304) ..... I 

Morphine-N-oxide (9307) ............. I 

Normorphine (9313) ..................... I 

Pholcodine (9314) ........................ I 

Acetylmethadol (9601) ................. I 

Allylprodine (9602) ....................... I 

Alphacetylmethadol except levoalphacetylmethadol (9603).I 

Alphameprodine (9604) ................ I 

Alphamethadol (9605) .................. I 

Betacetylmethadol (9607) ............ I 

Betameprodine (9608) .................. I 

Betamethadol (9609) .................... I 

Betaprodine (9611) ....................... I 

Hydroxypethidine (9627) .............. I 

Noracymethadol (9633) ................ I 

Norlevorphanol (9634) .................. I 

Normethadone (9635) .................. I 

Trimeperidine (9646) .................... I 

Phenomorphan (9647) ................. I 

1–Methyl-4-phenyl-4- 

propionoxypiperidine (9661).

I 

Para-Fluorofentanyl (9812) .......... I 

3–Methylfentanyl (9813) ............... I 

Alpha-Methylfentanyl (9814) ........ I 

Acetyl-alpha-methylfentanyl 

(9815).

I 

Beta-hydroxyfentanyl (9830) ........ I 

Beta-hydroxy-3-methylfentanyl 

(9831).

I 

Alpha-Methylthiofentanyl (9832) ... I 

3–Methylthiofentanyl (9833) ......... I 

Thiofentanyl (9835) ...................... I 

Amphetamine (1100) .................... II 

Methamphetamine (1105) ............ II 

Lisdexamfetamine (1205) ............. II 

Phenmetrazine (1631) .................. II 

Methylphenidate (1724) ................ II 

Amobarbital (2125) ....................... II 

Pentobarbital (2270) ..................... II 

Secobarbital (2315) ...................... II 

Glutethimide (2550) ...................... II 

Nabilone (7379) ............................ II 

1–Phenylcyclohexylamine (7460) II 

Phencyclidine (7471) .................... II 

1– 

Piperidinocyclohexanecarbonitrile (8603).

II 

Alphaprodine (9010) ..................... II 

Cocaine (9041) ............................. II 

Codeine (9050) ............................. II 

Dihydrocodeine (9120) ................. II 

Oxycodone (9143) ........................ II 

Drug Schedule 

Hydromorphone (9150) ................ II 

Diphenoxylate (9170) ................... II 

Benzoylecgonine (9180) ............... II 

Ethylmorphine (9190) ................... II 

Hydrocodone (9193) ..................... II 

Levomethorphan (9210) ............... II 

Levorphanol (9220) ...................... II 

Isomethadone (9226) ................... II 

Meperidine (9230) ........................ II 

Meperidine intermediate-A (9232) II 

Meperidine intermediate-B (9233) II 

Meperidine intermediate-C (9234) II 

Methadone (9250) ........................ II 

Methadone intermediate (9254) ... II 

Dextropropoxyphene, bulk (nondosage forms) (9273).II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Levo-alphacetylmethadol (9648) .. II 

Oxymorphone (9652) ................... II 

Noroxymorphone (9668) .............. II 

Racemethorphan (9732) .............. II 

Alfentanil (9737) ........................... II 

Sufentanil (9740) .......................... II 

Tapentadol (9780) ........................ II 

Fentanyl (9801) ............................ II 

The company plans to manufacture 

small quantities of the listed controlled 

substances to make reference standards 

which will be distributed to their 

customers. 

Any other such applicant, and any 

person who is presently registered with 

DEA to manufacture such substances, 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such written comments or 

objections should be addressed, in 

quintuplicate, to the Drug Enforcement 

Administration, Office of Diversion 

Control, Federal Register Representative 

(ODL), 8701 Morrissette Drive, 

Springfield, Virginia 22152; and must be 

filed no later than November 24, 2009. 

Dated: September 17, 2009. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. E9–23067 Filed 9–24–09; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

Proposed Extension of Information 

Collection; Request for Public 

Comment; Notice of Special 

Enrollment 

ACTION: Notice. 

SUMMARY: The Department of Labor 

(Department), as part of its continuing 

effort to reduce paperwork and 

respondent burden, conducts a 

preclearance consultation program to 

provide the general public and Federal 

agencies with an opportunity to 

comment on proposed and continuing 

collections of information in accordance 

with the Paperwork Reduction Act of 

1995 (PRA) (44 U.S.C. 3506(c)(2)((A)). 

This program helps to ensure that the 

data the Department gathers can be 

provided in the desired format, that the 

reporting burden on the public (time 

and financial resources) is minimized, 

that the public understands the 

Department’s collection instruments, 

and that the Department can accurately 

assess the impact of collection 

requirements on respondents. 

Currently, the Employee Benefits 

Security Administration (EBSA) is 

soliciting comments concerning the 

extension of a currently approved 

collection of information arising from 

the Department’s regulation at 29 CFR 

2590.701–6, which requires a notice of 

special enrollment to be provided to 

employees who are offered an initial 

opportunity to enroll in a group health 

plan. A copy of the information 

collection request (ICR) can be obtained 

by contacting the office shown in the 

ADDRESSES section of this notice. 

DATES: Written comments must be 

submitted to the office shown in the 

ADDRESSES section of this notice on or 

before November 24, 2009. 

ADDRESSES: Interested parties are 

invited to submit written comments 

regarding the information collection 

request and burden estimates to G. 

Christopher Cosby, Office of Policy and 

Research, Employee Benefits Security 

Administration, U.S. Department of 

Labor, 200 Constitution Avenue, NW., 

Room N–5718, Washington, DC 20210, 

(202) 693–8410, FAX (202) 219–4745 

(these are not toll-free numbers). 

Comments may also be submitted 

electronically to the following Internet 

e-mail address: ebsa.opr@dol.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

Subsection (c) of 29 CFR 2590.701–6 

requires group health plans to provide 

a notice describing the plan’s special 

enrollment rules to each employee who 

is offered an initial opportunity to enroll 

in the group health plan. The special 

enrollment rules described in the notice 

of special enrollment generally provide 

enrollment rights to employees and 

their dependents in specified 

circumstances occurring after the 

employee or dependent initially 

declines to enroll in the plan. EBSA 

previously submitted an ICR concerning 


jlentini on DSKJ8SOYB1PROD with NOTICES
49022 Federal Register / Vol. 74, No. 185 / Friday, September 25, 2009 / Notices 

the notice of special enrollment to the 

Office of Management and Budget 

(OMB) for review under the PRA and 

received approval under OMB Control 

No. 1210–0101. The ICR approval is 

currently scheduled to expire on 

December 31, 2009. 

II. Desired Focus of Comments 

The Department is particularly 

interested in comments that: 

• Evaluate whether the collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 

• Evaluate the accuracy of the 

agency’s estimate of the burden of the 

collection of information, including the 

validity of the methodology and 

assumptions used; 

• Enhance the quality, utility, and 

clarity of the information to be 

collected; and 

• Minimize the burden of the 

collection of information on those who 

are to respond, including through the 

use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology, 

e.g., by permitting electronic submission 

of responses. 

III. Current Action 

This notice requests comments on an 

extension of information collections 

arising from the notice of special 

enrollment required under 29 CFR 

2590.701–6. The Department is not 

proposing or implementing changes to 

the existing information collection at 

this time. A summary of the ICR and the 

current burden estimates follows: 

Agency: Department of Labor, 

Employee Benefits Security 

Administration. 

Title: Notice of Special Enrollment. 

Type of Review: Extension of a 

currently approved collection of 

information. 

OMB Number: 1210–0101. 

Affected Public: Business or other forprofit; Not-for-profit institutions. 

Frequency of Response: On occasion. 

Respondents: 2,600,000. 

Responses: 8,568,282. 

Total Estimated Burden Hours: 1. 

Total Burden Cost (Operating and 

Maintenance): $77,115. 

Comments submitted in response to 

this notice will be summarized and/or 

included in the request for OMB 

approval of the extension of this ICR; 

they will also become a matter of public 

record. 

Dated: September 21, 2009. 

Joseph S. Piacentini, 

Director, Office of Policy and Research, 

Employee Benefits Security Administration. 

[FR Doc. E9–23137 Filed 9–24–09; 8:45 am] 

BILLING CODE 4510–20–P 

DEPARTMENT OF LABOR 

Employee Benefits Security 

Administration 

Proposed Extension of Information 

Collection; Request for Public 

Comment for Class Prohibited 

Transaction Exemption 2006–16 

ACTION: Notice. 

SUMMARY: The Department of Labor 

(Department), as part of its continuing 

effort to reduce paperwork and 

respondent burden, conducts a 

preclearance consultation program to 

provide the general public and Federal 

agencies with an opportunity to 

comment on proposed and continuing 

collections of information in accordance 

with the Paperwork Reduction Act of 

1995 (PRA) (44 U.S.C. 3506(c)(2)(A)). 

This program helps to ensure that the 

data the Department gathers can be 

provided in the desired format, that the 

reporting burden on the public (time 

and financial resources) is minimized, 

that the public understands the 

Department’s collection instruments, 

and that the Department can accurately 

assess the impact of collection 

requirements on respondents. 

Currently, the Employee Benefits 

Security Administration (EBSA) is 

soliciting comments concerning the 

extension of currently approved 

collections of information arising from 

Class Prohibited Transaction Exemption 

2006–16, which permits employee 

benefit plans to lend securities owned 

by the plans as investments to banks 

and broker-dealers and to make 

compensation arrangements for lending 

services provided by a plan fiduciary in 

connection with securities loans. A 

copy of the information collection 

request (ICR) can be obtained by 

contacting the office shown in the 

ADDRESSES section of this notice. 

DATES: Written comments must be 

submitted to the office shown in the 

ADDRESSES section of this notice on or 

before November 24, 2009. 

ADDRESSES: Interested parties are 

invited to submit written comments 

regarding the information collection 

request and burden estimates to G. 

Christopher Cosby, Office of Policy and 

Research, Employee Benefits Security 

Administration, U.S. Department of 

Labor, 200 Constitution Avenue, NW., 

Room N–5718, Washington, DC 20210, 

(202) 693–8410, FAX (202) 219–4745 

(these are not toll-free numbers). 

Comments may also be submitted 

electronically to the following Internet 

e-mail address: ebsa.opr@dol.gov. 

SUPPLEMENTARY INFORMATION: 

I. Background 

This ICR covers information 

collections contained in PTE 2006–16. 

In 1981 and 1982, the Department 

issued two related prohibited 

transaction class exemptions, PTE 81–6 

and PTE 82–63, that permit employee 

benefit plans to lend securities owned 

by the plans as investments to banks 

and broker-dealers and to make 

compensation arrangements for lending 

services provided by a plan fiduciary in 

connection with securities loans. In 

2006, the Department promulgated PTE 

2006–16, which combines and amends 

the exemptions previously provided 

under PTE 81–6 and PTE 82–63. The 

new exemption expands the categories 

of exempted transactions to include 

securities lending to foreign banks and 

broker-dealers that are domiciled in 

specified countries and to allow the use 

of additional forms of collateral, all 

subject to specified conditions. 

Among other conditions, the class 

exemption requires that a bank or 

broker-dealer that borrows securities 

from a plan must provide the plan with 

its most recent audited financial 

statement. The borrower must also 

affirm, when the loan is negotiated, that 

there has been no material adverse 

change in its financial condition since 

the previously audited statement. 

The exemption also requires that the 

agreements regarding the securities loan 

transaction or transactions and the 

compensation arrangement for the 

lending fiduciary must be contained in 

written documents. Individual 

agreements are not required for each 

transaction; rather the compensation 

agreement may be made in the form of 

a master agreement covering a series of 

transactions. The ICRs contained in PTE 

2006–16 were approved by the Office of 

Management and Budget (OMB) under 

OMB Control No. 1210–0065, which 

currently is scheduled to expire on 

December 31, 2009. 

II. Desired Focus of Comments 

The Department is particularly 

interested in comments that: 

• Evaluate whether the collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether the 

information will have practical utility; 


jlentini on DSKJ8SOYB1PROD with NOTICES